发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report UEGW 2022最新文献

筛选
英文 中文
Computer-aided colonoscopies improved adenoma detection rates 计算机辅助结肠镜检查提高了腺瘤的检出率
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-02 DOI: 10.55788/1ae8335a
S. Kammerer
{"title":"Computer-aided colonoscopies improved adenoma detection rates","authors":"S. Kammerer","doi":"10.55788/1ae8335a","DOIUrl":"https://doi.org/10.55788/1ae8335a","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125128028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fewer long-term interventions after delayed drainage in necrotising pancreatitis 坏死性胰腺炎延迟引流后的长期干预较少
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-02 DOI: 10.55788/19b4f437
S. Kammerer
{"title":"Fewer long-term interventions after delayed drainage in necrotising pancreatitis","authors":"S. Kammerer","doi":"10.55788/19b4f437","DOIUrl":"https://doi.org/10.55788/19b4f437","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"238 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124621902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose-interval of adalimumab might be prolonged in CD patients in stable remission 阿达木单抗在稳定缓解的乳糜泻患者中可能会延长剂量间隔
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/6f4de4da
S. Kammerer
{"title":"Dose-interval of adalimumab might be prolonged in CD patients in stable remission","authors":"S. Kammerer","doi":"10.55788/6f4de4da","DOIUrl":"https://doi.org/10.55788/6f4de4da","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115110991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustained maintenance results with upadacitinib in UC upadacitinib治疗UC的持续维持效果
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/5d4af2e9
S. Kammerer
{"title":"Sustained maintenance results with upadacitinib in UC","authors":"S. Kammerer","doi":"10.55788/5d4af2e9","DOIUrl":"https://doi.org/10.55788/5d4af2e9","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132739378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fast recapture of response with ozanimod after withdrawal in UC UC停药后ozanimod快速恢复反应
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/49a646b8
S. Kammerer
{"title":"Fast recapture of response with ozanimod after withdrawal in UC","authors":"S. Kammerer","doi":"10.55788/49a646b8","DOIUrl":"https://doi.org/10.55788/49a646b8","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126964810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small molecule obefazimod shows promise in UC 小分子obefazimod在UC中显示出希望
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/efbf9245
S. Kammerer
{"title":"Small molecule obefazimod shows promise in UC","authors":"S. Kammerer","doi":"10.55788/efbf9245","DOIUrl":"https://doi.org/10.55788/efbf9245","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116762231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mirikizumab successfully resolves active histologic inflammation in UC Mirikizumab成功地解决了UC的活动性组织学炎症
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/abaaf5dd
S. Kammerer
{"title":"Mirikizumab successfully resolves active histologic inflammation in UC","authors":"S. Kammerer","doi":"10.55788/abaaf5dd","DOIUrl":"https://doi.org/10.55788/abaaf5dd","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124873485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Another chance for TYK2 inhibition in UC 另一个在UC中抑制TYK2的机会
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/7265b8cf
S. Kammerer
{"title":"Another chance for TYK2 inhibition in UC","authors":"S. Kammerer","doi":"10.55788/7265b8cf","DOIUrl":"https://doi.org/10.55788/7265b8cf","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121506507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Start low with brepocitinib and ritlecitinib in UC UC低剂量开始使用brepositinib和ritlecitinib
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/d673eaa0
S. Kammerer
{"title":"Start low with brepocitinib and ritlecitinib in UC","authors":"S. Kammerer","doi":"10.55788/d673eaa0","DOIUrl":"https://doi.org/10.55788/d673eaa0","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131195969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ozanimod treatment prompted substantial response after failure of response to induction 在诱导反应失败后，Ozanimod治疗引起了实质性的反应
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/83087d65
S. Kammerer
{"title":"Ozanimod treatment prompted substantial response after failure of response to induction","authors":"S. Kammerer","doi":"10.55788/83087d65","DOIUrl":"https://doi.org/10.55788/83087d65","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132436723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信